James D Lechleiter

Professor, Cell Systems & Anatomy

Phone+1-210-562-4043
Emaillechleiter@uthscsa.edu

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where James D Lechleiter is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

6 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

1 Active
2 Not started
8 Finished

PEPTIDERGIC CONTROL OF PREOCULAR TEAR FILM SECRETION
Lechleiter, J. D.
National Institutes of Health
6/24/85 → …
Project: Research project
Regulation of ER-stress Activated UPR kinase PERK in Neurodegenerative Diseases
Lechleiter, J. D.
Project: Research project
Astrocyte activation by small-molecule ADORA3 agonists: a novel therapy for Alzheimer's disease
Lechleiter, J. D.
Project: Research project
ASTROCYTE ACTIVATION BY SMALL MOLECULE P2Y1 AGONISTS FOR TREATMENT OF TBI
Lechleiter, J. D.
National Institutes of Health
9/30/15 → 6/30/17
Project: Research project
San Antonio Biomedical Education and Research
Lechleiter, J. D., McManus, L. M., Mcmanus, L. M. & Oyajobi, B.
National Institutes of Health
7/1/15 → 3/31/20
Project: Research project

5899 Citations
36 h-Index
67 Article
4 Review article
1 Chapter
1 Conference article
More

A Mouse Model of Repetitive Blast Traumatic Brain Injury Reveals Post-Trauma Seizures and Increased Neuronal Excitability
Bugay, V., Bozdemir, E., Vigil, F. A., Chun, S. H., Holstein, D. M., Elliott, W. R., Sprague, C. J., Cavazos, J. E., Zamora, D. O., Rule, G., Shapiro, M. S., Lechleiter, J. D. & Brenner, R., Jan 15 2020, In: Journal of Neurotrauma. 37, 2, p. 248-261 14 p.
Research output: Contribution to journal › Article › peer-review
9 Scopus citations
Nucleotide P2Y₁ receptor agonists are in vitro and in vivo prodrugs of A₁/A₃ adenosine receptor agonists: implications for roles of P2Y₁ and A₁/A₃ receptors in physiology and pathology
Liston, T. E., Hinz, S., Müller, C. E., Holstein, D. M., Wendling, J., Melton, R. J., Campbell, M., Korinek, W. S., Suresh, R. R., Sethre-Hofstad, D. A., Gao, Z. G., Tosh, D. K., Jacobson, K. A. & Lechleiter, J. D., Dec 2020, In: Purinergic Signalling. 16, 4, p. 543-559 17 p.
Research output: Contribution to journal › Article › peer-review
1 Scopus citations
Prevention of brain damage after traumatic brain injury by pharmacological enhancement of KCNQ (Kv7, “M-type”) K⁺ currents in neurons
Vigil, F. A., Bozdemir, E., Bugay, V., Chun, S. H., Hobbs, M. A., Sanchez, I., Hastings, S. D., Veraza, R. J., Holstein, D. M., Sprague, S. M., M Carver, C., Cavazos, J. E., Brenner, R., Lechleiter, J. D. & Shapiro, M. S., Jun 1 2020, In: Journal of Cerebral Blood Flow and Metabolism. 40, 6, p. 1256-1273 18 p.
Research output: Contribution to journal › Article › peer-review
13 Scopus citations
Time to target stroke: Examining the circadian system in stroke
Stubblefield, J. J. & Lechleiter, J. D., 2019, In: Yale Journal of Biology and Medicine. 92, 2, p. 349-357 9 p.
Research output: Contribution to journal › Short survey › peer-review
1 Scopus citations
Inhibition of mTOR protects the blood-brain barrier in models of Alzheimer’s disease and vascular cognitive impairment
Van Skike, C. E., Jahrling, J. B., Olson, A. B., Sayre, N. L., Hussong, S. A., Ungvari, Z., Lechleiter, J. D. & Galvan, V., Apr 2018, In: American Journal of Physiology - Heart and Circulatory Physiology. 314, 4, p. H693-H703
Research output: Contribution to journal › Article › peer-review
42 Scopus citations

Candidacy Ceremony 2020 version
Barbara A Christy, Lily Q Dong, Nu Zhang, Teppei Fujikawa, Carie Boychuk, Jessica Nute, Karl Rasmussen, James F Nelson, Kenneth M Hargreaves, Erzsebet K Cearley, Azizeh K Sowan, Pei Wang, Tyler J Curiel, Alexander J Bishop, Thomas G Boyer, Sara L Gill, Alan Frazer, Lisa M Cleveland, James D Lechleiter, Kexin Xu, Lizhen Chen, Paolo Casali, Kumar Sharma, Sarah C Hopp, Evelien M Bunnik, Susan E Frost, Elizabeth Leadbetter & Patrick M Sung
8/31/20
1 item of Media coverage
Press/Media: Press / Media
Novel therapy administered after TBI prevents brain damage
Mark S Shapiro, Robert Brenner & James D Lechleiter
7/16/19 → 7/17/19
4 items of Media coverage
Press/Media: Press / Media
University of Texas Health Science Center-San Antonio: Novel Therapy Administered After TBI Prevents Brain Damage
Mark S Shapiro, Robert Brenner & James D Lechleiter
7/13/19
1 item of Media coverage
Press/Media: Press / Media
Global Neuroprotection Drugs Market is Expected
James D Lechleiter
7/11/19
1 item of Media coverage
Press/Media: Press / Media
Global Neuroprotection Drugs Market is Expected to Reach US$ 33,481.7 Million by 2027, Growing at an Estimated CAGR of 1.56% Over the Forecast Period, Says Absolute Markets Insights
James D Lechleiter
7/11/19
8 items of Media coverage
Press/Media: Press / Media